|
To learn more about Genentech Patient Support Services, click here.
• ADC Advancing Patient Support
• Immunocore's Kimmtrak Connect
• Novartis Patient Assistance Foundation Details >
New, retired, and revised policies/articlesDetails >• Guidance on Review Issues Related to Ascension's Cyber Incident
• Website Updates
• Expedited Prior Authorization Requests
• Medicare Hot Links
• And More Details >New training opportunities availableDetails >
Recent Oncology Related Articles• OCM Final Evaluation
• Hospital Price Transparency
• Quarter 4 Edit Files
• MLN Matters
• And More Details >• How to Participate in MIPS as a Group
• MIPS EUC Policy
• Targeted Review Available Until October 11 Details >This edition includes articles on• Medicare Advantage Plan Sort Of Responds to CMS Complaint
• Little-known Benefits of the Two-Night Rule
• Crushing Drainage Coding Challenges with Complex Case Analysis
• Important Information Concerning Aetna
• Navigators: A Big Healthcare Investment Details >
Recent Oncology Related News• Update to Clinical Editing Billing Tips
• Coming Soon: New Member Site Features
• Paying Brand-Name Drugs That Have Generic Equivalents Available Details >Publications• The Record
• BCN Provider News Details >
Last Reviewed/Updated 9-16-24• BCBSM Below Cost Reimbursement
• 0885 Claims Denied
• Procrit Denials (693)
• Procrit or Epoetin Class Drugs Maintenance
• And More Details >Last Reviewed/Updated 9-16-24• BCBSM Carelon Letter Details >• Policy Updates
• Medical Education & Training
• Coverage Policies Details >• Billing for Medicare Advantage in Hospice Coordination Period
• Reminder - Important Contacts to Help You
• Prior Auth Requirements, Policy Updates, & Pharmacy Info
• Keep Provider Information Updated in NPPES Details >• Pharmacy News
• Claims Payment Policies
• Claims Coding, Inquiry Process Guidelines
• Prior Auth & Notification Lists Details >• DBM Preliminary Payments Were Mailed
• Peer-to-Peer Policy Update
• Updated 2024 HEDIS Provider Reference Guide
• Updated 2024 PIP Manual Now Available
• Rad/Onc Auth. Program With EviCore Launches Sept. 15 Details >• Reimbursement Policy Updates
• Medical Policy Updates
• Q4 2024 Preferred Drug List Updates
• Cancer Support Program
• And More Details >
• Novartis Tecentriq Hybreza
• Genentech Kisqali (ribociclib)
• Merck Keytruda (pembrolizumab) Details > 
September 2024 Frequently Asked Questions• Red Flags When Reviewing Infusion & Injection Claims
• Billing Code 95180 & Chemotherapy
• White Bagging VS Brown Bagging
• IV Hydration With Multiple Drugs Details > |
